UBS Maintains a 'Buy' on Noble Energy (NBL); Raising NAV for Leviathan and Niobrara
Get Alerts NBL Hot Sheet
Price: $8.46 --0%
Rating Summary:
23 Buy, 18 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
23 Buy, 18 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Buy' on Noble Energy (NYSE: NBL), PT increased from $106 to $110.
UBS analyst says, "We see several catalysts that could propel NBL’s share prices: 1) Better than expected 1Q11 results on higher Israeli gas volumes due to Egyptian disruption (UBSe of $1.20/$3.02 vs. cons of $1.10/$2.79); 2) potential reduction in Egyptian exports to Israel may enable higher medium term production from Mari-B & accelerated development of Tamar; 3) large, but high risk, resource potential from 2 oil prospects at Leviathan albeit delayed till possibly 2H11 from May (~$5.0/sh on risk-adjusted basis); 4) 2H11 exploration & ongoing Niobrara results."
For more ratings news on Noble Energy click here and for the rating history of Noble Energy click here.
Shares of Noble Energy closed at $97.21 yesterday.
UBS analyst says, "We see several catalysts that could propel NBL’s share prices: 1) Better than expected 1Q11 results on higher Israeli gas volumes due to Egyptian disruption (UBSe of $1.20/$3.02 vs. cons of $1.10/$2.79); 2) potential reduction in Egyptian exports to Israel may enable higher medium term production from Mari-B & accelerated development of Tamar; 3) large, but high risk, resource potential from 2 oil prospects at Leviathan albeit delayed till possibly 2H11 from May (~$5.0/sh on risk-adjusted basis); 4) 2H11 exploration & ongoing Niobrara results."
For more ratings news on Noble Energy click here and for the rating history of Noble Energy click here.
Shares of Noble Energy closed at $97.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- Oppenheimer Reiterates Outperform Rating on NVIDIA (NVDA) Into EPS
- Jefferies Downgrades Sunway Healthcare Holdings (SUNMED:MK) to Hold
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share